Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2010 1
2012 1
2013 4
2014 3
2015 3
2016 2
2017 3
2018 3
2019 7
2020 6
2021 7
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy.
Hirano T, Hayashi T, Sugita H, Tamasawa A, Goto S, Tomoyasu M, Yamamoto T, Ohara M, Terasaki M, Kushima H, Ito Y, Yamagishi SI, Mori Y. Hirano T, et al. Among authors: ohara m. J Diabetes Investig. 2023 Dec;14(12):1401-1411. doi: 10.1111/jdi.14076. Epub 2023 Aug 30. J Diabetes Investig. 2023. PMID: 37647503 Free PMC article. Clinical Trial.
Anti-inflammatory and atheroprotective properties of glucagon.
Osaka N, Kushima H, Mori Y, Saito T, Hiromura M, Terasaki M, Yashima H, Ohara M, Fukui T, Matsui T, Hirano T, Yamagishi SI. Osaka N, et al. Among authors: ohara m. Diab Vasc Dis Res. 2020 May-Jun;17(5):1479164120965183. doi: 10.1177/1479164120965183. Diab Vasc Dis Res. 2020. PMID: 33076703 Free PMC article.
Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study.
Omachi T, Ohara M, Fujikawa T, Kohata Y, Sugita H, Irie S, Terasaki M, Mori Y, Fukui T, Yamagishi SI. Omachi T, et al. Among authors: ohara m. Diabetes Ther. 2024 Jan;15(1):111-126. doi: 10.1007/s13300-023-01493-3. Epub 2023 Oct 25. Diabetes Ther. 2024. PMID: 37880502 Free PMC article.
Efficacy of a new enzyme-linked immunosorbent assay system for three islet cell autoantibodies in Japanese patients with acute-onset type 1 diabetes.
Fukui T, Takehana N, Mori Y, Hiromura M, Terasaki M, Kushima H, Takada M, Tomoyasu M, Sato N, Hayashi T, Ohara M, Kikuchi T, Ito Y, Kobayashi T, Yamagishi SI. Fukui T, et al. Among authors: ohara m. Endocr J. 2022 Nov 28;69(11):1343-1349. doi: 10.1507/endocrj.EJ22-0146. Epub 2022 Jun 24. Endocr J. 2022. PMID: 35753761 Free article.
Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
Takehana N, Fukui T, Mori Y, Hiromura M, Terasaki M, Ohara M, Takada M, Tomoyasu M, Ito Y, Kobayashi T, Yamagishi SI. Takehana N, et al. Among authors: ohara m. J Diabetes Investig. 2023 Jul;14(7):856-863. doi: 10.1111/jdi.14016. Epub 2023 Apr 20. J Diabetes Investig. 2023. PMID: 37082800 Free PMC article.
47 results